🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial tests the safety, side effects, and best dose of ZEN0036...
Status
Recruiting
Location
Keck Medicine of USC Koreatown
Start Date
2023-08-10
Trial ID
NCT05372640
This is a two-part open label, non-randomized, Phase 2, study of ZEN003694 ...
Status
Terminated
Location
Banner MD Anderson Cancer Center
Start Date
2019-06-26
Trial ID
NCT03901469
Treatments Being Tested
This phase I/Ib trial is to find out the best dose, possible benefits and/o...
Status
Suspended
Location
National Cancer Institute Developmental Therapeutics Clinic
Start Date
2022-02-02
Trial ID
NCT04840589
This phase I trial tests the safety, side effects, and best dose of ZEN0036...
Status
Recruiting
Location
Los Angeles General Medical Center
Start Date
2022-07-13
Trial ID
NCT05019716
This is an open label, Phase 1, dose escalation and dose confirmation study...
Status
Completed
Location
University of California Los Angeles Medical Center
Start Date
2016-05
Trial ID
NCT02705469
Treatments Being Tested
This phase I/II trial tests the safety, side effects, and best dose of enti...
Status
Recruiting
Location
Yale University
Start Date
2022-11-16
Trial ID
NCT05053971
Treatments Being Tested
This phase Ib trial tests the safety and tolerability of ZEN003694 in combi...
Status
Recruiting
Location
Boston Medical Center
Start Date
2023-05-18
Trial ID
NCT05422794
This is an open label, non-randomized, Phase 1b/2a, dose escalation and dos...
Status
Completed
Location
University of California Los Angeles Medical Center
Start Date
2016-12
Trial ID
NCT02711956
Treatments Being Tested
This Phase I, open label, dose determining study of oral niraparib in combi...
Status
Withdrawn
Location
UPMC Magee Womens Hospital
Start Date
2024-01-23
Trial ID
NCT06161493
This phase I trial tests the safety, best dose, and effectiveness of ZEN003...
Status
Suspended
Location
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Start Date
2024-06-05
Trial ID
NCT06102902